EFFECT OF RYANODINE ON SARCOPLASMIC-RETICULUM CA2+ ACCUMULATION IN NONFAILING AND FAILING HUMAN MYOCARDIUM

被引:33
作者
NIMER, LR
NEEDLEMAN, DH
HAMILTON, SL
KRALL, J
MOVSESIAN, MA
机构
[1] UNIV UTAH, HLTH SCI CTR,SCH MED,DEPT INTERNAL MED CARDIOL, DIV CARDIOL, SALT LAKE CITY, UT 84132 USA
[2] VET AFFAIRS MED CTR, RES SERV, SALT LAKE CITY, UT USA
[3] UNIV UTAH, SCH MED, DEPT PHARMACOL, SALT LAKE CITY, UT USA
[4] BAYLOR COLL MED, DEPT PHYSIOL & MOLEC BIOPHYS, HOUSTON, TX USA
关键词
SARCOPLASMIC RETICULUM; CARDIOMYOPATHY; CALCIUM; CALCIUM CHANNELS; HEART FAILURE;
D O I
10.1161/01.CIR.92.9.2504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The purpose of this study was to determine whether abnormal Ca2+ release through ryanodine-sensitive Ca2+ channels in the sarcoplasmic reticulum might contribute to the abnormal [Ca2+](i) homeostasis that has been described in failing human myocardium. Methods and Results Occupancy of low-affinity ryanodine binding sites on ryanodine-sensitive Ca2+ channels stimulates oxalate-supported, ATP-dependent Ca2+ accumulation in sarcoplasmic reticulum-derived microsomes by inhibiting concurrent Ca2+ efflux through these channels. We examined the effects of 0.5 mmol/L ryanodine on Ca-45(2+) accumulation in microsomes prepared from nonfailing (n=8) and failing (n=10) human left ventricular myocardium. In the absence of ryanodine, Ca-45(2+) accumulation reached similar levels in microsomes from nonfailing and failing hearts. Incubation with 0.5 mmol/L ryanodine caused a 52.2+/-6.5% increase in peak Ca-45(2+) accumulation in microsomes from nonfailing hearts and a 24.3+/-4.1% increase in microsomes from failing hearts. The density of high-affinity ryanodine binding sites and the inhibition of [H-3]ryanodine dissociation from these sites by 0.1 mmol/L ryanodine were similar in microsomes from nonfailing and failing hearts. Conclusions These results, which demonstrate a diminished stimulation of Ca2+ accumulation by ryanodine in sarcoplasmic reticulum-derived microsomes from failing human myocardium that could be explained by an uncoupling of the occupancy of low-affinity ryanodine binding sites from the reduction in the open probability of these channels or by concurrent Ca2+ efflux through a ryanodine-insensitive mechanism, are evidence that increased efflux of Ca2+ from the sarcoplasmic reticulum may contribute to the abnormal [Ca2+](i) homeostasis described in failing human myocardium.
引用
收藏
页码:2504 / 2510
页数:7
相关论文
共 44 条
[1]   EFFECT OF PERFUSATE [CA-2+] ON CARDIAC SARCOPLASMIC-RETICULUM CA-2+ RELEASE CHANNEL IN ISOLATED RAT HEARTS [J].
ABDELMEGUID, AE ;
FEHER, JJ .
CIRCULATION RESEARCH, 1992, 71 (05) :1049-1058
[2]  
ANDERSON K, 1989, J BIOL CHEM, V264, P1329
[3]   INOSITOL PHOSPHATES AND CELL SIGNALING [J].
BERRIDGE, MJ ;
IRVINE, RF .
NATURE, 1989, 341 (6239) :197-205
[4]   INTRACELLULAR CALCIUM HANDLING IN ISOLATED VENTRICULAR MYOCYTES FROM PATIENTS WITH TERMINAL HEART-FAILURE [J].
BEUCKELMANN, DJ ;
NABAUER, M ;
ERDMANN, E .
CIRCULATION, 1992, 85 (03) :1046-1055
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   DIFFERENCES IN CARDIAC CALCIUM RELEASE CHANNEL (RYANODINE RECEPTOR) EXPRESSION IN MYOCARDIUM FROM PATIENTS WITH END-STAGE HEART-FAILURE CAUSED BY ISCHEMIC VERSUS DILATED CARDIOMYOPATHY [J].
BRILLANTES, AM ;
ALLEN, P ;
TAKAHASHI, T ;
IZUMO, S ;
MARKS, AR .
CIRCULATION RESEARCH, 1992, 71 (01) :18-26
[7]   STABILIZATION OF CALCIUM-RELEASE CHANNEL (RYANODINE RECEPTOR) FUNCTION BY FK506-BINDING PROTEIN [J].
BRILLANTES, AMB ;
ONDRIAS, K ;
SCOTT, A ;
KOBRINSKY, E ;
ONDRIASOVA, E ;
MOSCHELLA, MC ;
JAYARAMAN, T ;
LANDERS, M ;
EHRLICH, BE ;
MARKS, AR .
CELL, 1994, 77 (04) :513-523
[8]   BETA-1-ADRENERGIC-RECEPTOR AND BETA-2-ADRENERGIC-RECEPTOR SUBPOPULATIONS IN NONFAILING AND FAILING HUMAN VENTRICULAR MYOCARDIUM - COUPLING OF BOTH RECEPTOR SUBTYPES TO MUSCLE-CONTRACTION AND SELECTIVE BETA-1-RECEPTOR DOWN-REGULATION IN HEART-FAILURE- [J].
BRISTOW, MR ;
GINSBURG, R ;
UMANS, V ;
FOWLER, M ;
MINOBE, W ;
RASMUSSEN, R ;
ZERA, P ;
MENLOVE, R ;
SHAH, P ;
JAMIESON, S ;
STINSON, EB .
CIRCULATION RESEARCH, 1986, 59 (03) :297-309
[9]  
CHU A, 1990, MOL PHARMACOL, V37, P735
[10]  
Cleland W W, 1979, Methods Enzymol, V63, P103